Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan-Reference-Cited by-同舟云学术

Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan

Published:2023-07-13 Issue:1 Volume:20 Page:216-223
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

Jones Paul¹^ORCID,Hataji Osamu²,Suzukamo Yoshimi³^ORCID,Crawford Bruce⁴,Sakai Yoko⁴,Ishii Takeo⁵^ORCID,Sato Keiko⁵⁶^ORCID,Sasaki Eri⁵,Hashimoto Kenichi⁵^ORCID,Oga Toru⁷

Affiliation:

1. GSK, Brentford, Middlesex, UK

2. Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Mie, Japan

3. Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

4. Real World Evidence, Syneos Health, Tokyo, Japan

5. Value Evidence Outcomes Respiratory Department, Japan Medical & Development, GSK K.K., Tokyo, Japan

6. Information Technology Center, The University of Tokyo, Tokyo, Japan

7. Kawasaki Medical School, Kurashiki, Okayama, Japan

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15412555.2023.2219742

Reference27 articles.

1. Global strategy for prevention diagnosis and management of COPD 2021 report – Global initiative for chronic obstructive lung disease [Internet]. [cited 2021 Aug 5]. Available from: https://goldcopd.org/

2. The JRS Guideline for the Management of Chronic Obstructive Pulmonary Disease 2022 – Japanese Respiratory Society The Committee for the Sixth Edition of the COPD Guidelines of The Japanese Respiratory Society [Internet]. [cited 2022 Aug 18]. Available from: https://www.jrs.or.jp/publication/jrs_guidelines/20220512084311.html

3. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

4. Impact and prevention of severe exacerbations of COPD: a review of the evidence

5. Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease